Concepedia

Susana Salgado-Pires

SS

Statistics

Publications

5

Citations

336

H-Index

5

Active since

2014

Affiliations

Light Chain Bioscience (Switzerland)(Current)

Inserm

University of Geneva

Susana Salgado-Pires is an author at Light Chain Bioscience (Switzerland) specializing in immunology, bispecific antibodies, and tumor immunology.

Publications per year

2014–2023

5

Publications

5

Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies

Elie Dheilly, Valéry Moine, Lucile Broyer et al. · Molecular Therapy · 2017 · 142 citations · Full text

, , +17

Preclinical Development of a Bispecific Antibody that Safely and Effectively Targets CD19 and CD47 for the Treatment of B-Cell Lymphoma and Leukemia

Vanessa Buatois, Zoë Johnson, Susana Salgado-Pires et al. · Molecular Cancer Therapeutics · 2018 · 114 citations · Full text

, , +17

Selective Antibody Intervention of Toll-like Receptor 4 Activation through Fc γ Receptor Tethering

Limin Shang, Bruno Daubeuf, Martha Triantafilou et al. · Journal of Biological Chemistry · 2014 · 39 citations · Full text

, , +12

Toll-Like Receptor 4 on both Myeloid Cells and Dendritic Cells Is Required for Systemic Inflammation and Organ Damage after Hemorrhagic Shock with Tissue Trauma in Mice

Kent R. Zettel, Sebastian Korff, Rubén Zamora et al. · Frontiers in Immunology · 2017 · 23 citations · Full text

, , +17

Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancers

Anja Seckinger, Sara Majocchi, Valéry Moine et al. · Journal of Hematology & Oncology · 2023 · 18 citations · Full text

, , +17

1–5 of 5